Oncolytics Biotech Inc T.ONC

Alternate Symbol(s): ONCY

Healthcare Biotechnology

Oncolytics Biotech Inc. is a biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to phase 3 licensure-enabling studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.

TSX:ONC - Post by User

Oncolytics Biotech Inc > New Company Website URL

<< Previous

Bullboard Posts

Next >>

Comment by Reidism29on Sep 27, 2023 9:34pm

100 Views

Post# 35658382

RE:New Company Website URL

I like it. Very appealing and user friendly. Looks like it is targeting potential patients.
Transition is a little rough- old website is down and redirect is not working. Note the new URL.

<< Previous

Bullboard Posts

Next >>

Geologica Resource: Polymetallic upside at a depressed price